TrialJAMA ophthalmology2025

IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients: The RESTORE-1 Randomized Clinical Trial.

Haiyang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.